AS
Altshuler Shaham Portfolio holdings
AUM
$3.14B
1-Year Return
24.55%
This Quarter Return
+9.13%
1 Year Return
+24.55%
3 Year Return
+51.84%
5 Year Return
+71.45%
10 Year Return
–
AUM
$3.51B
AUM Growth
+$911M
(+35%)
Cap. Flow
+$618M
Cap. Flow
% of AUM
17.62%
Top 10 Holdings %
Top 10 Hldgs %
73.36%
Holding
670
New
145
Increased
254
Reduced
109
Closed
107
Top Buys
| 1 |
Simon Property Group
SPG
|
+$184M |
| 2 |
Elbit Systems
ESLT
|
+$149M |
| 3 |
Nice
NICE
|
+$93.8M |
| 4 |
ICL Group
ICL
|
+$51.1M |
| 5 |
Open Text
OTEX
|
+$36.6M |
Top Sells
| 1 |
Fortinet
FTNT
|
+$46.1M |
| 2 |
Alibaba
BABA
|
+$18.3M |
| 3 |
Royal Caribbean
RCL
|
+$6.6M |
| 4 |
Spirit AeroSystems
SPR
|
+$4.46M |
| 5 |
CISN
Cision Ltd. Ordinary Share
CISN
|
+$3.26M |
Sector Composition
| 1 | Technology | 33.7% |
| 2 | Consumer Discretionary | 14.32% |
| 3 | Industrials | 10.7% |
| 4 | Real Estate | 5.42% |
| 5 | Materials | 2.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPTX
276
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $16K | ﹤0.01% |
+264
| New | +$16K |
|
277
Adaptive Biotechnologies
ADPT
$1.92B
| $15K | ﹤0.01% |
+515
| New | +$15K |
|
278
AMN Healthcare
AMN
$798M
| $15K | ﹤0.01% |
+233
| New | +$15K |
|
279
Digital Turbine
APPS
$495M
| $15K | ﹤0.01% |
2,074
-447
| -18% | -$3.23K |
|
280
Boston Scientific
BSX
$160B
| $15K | ﹤0.01% |
325
+103
| +46% | +$4.75K |
|
281
Cigna
CI
$80.6B
| $15K | ﹤0.01% |
+71
| New | +$15K |
|
282
CorVel
CRVL
$4.49B
| $15K | ﹤0.01% |
516
+186
| +56% | +$5.41K |
|
283
Amicus Therapeutics
FOLD
$2.43B
| $15K | ﹤0.01% |
+1,600
| New | +$15K |
|
284
Humana
HUM
$32.8B
| $15K | ﹤0.01% |
+41
| New | +$15K |
|
285
Prestige Consumer Healthcare
PBH
$3.25B
| $15K | ﹤0.01% |
+367
| New | +$15K |
|
286
Teleflex
TFX
$5.76B
| $15K | ﹤0.01% |
40
-5
| -11% | -$1.88K |
|
287
UnitedHealth
UNH
$315B
| $15K | ﹤0.01% |
+50
| New | +$15K |
|
|
EGRX
288
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $15K | ﹤0.01% |
251
+83
| +49% | +$4.96K |
|
|
LHCG
289
DELISTED
LHC Group LLC
LHCG
| $15K | ﹤0.01% |
106
+28
| +36% | +$3.96K |
|
290
Addus HomeCare
ADUS
$2.08B
| $14K | ﹤0.01% |
149
+32
| +27% | +$3.01K |
|
|
AMED
291
DELISTED
Amedisys
AMED
| $14K | ﹤0.01% |
84
+13
| +18% | +$2.17K |
|
292
Alphatec Holdings
ATEC
$2.34B
| $14K | ﹤0.01% |
2,032
+184
| +10% | +$1.27K |
|
293
Bruker
BRKR
$4.73B
| $14K | ﹤0.01% |
283
+63
| +29% | +$3.12K |
|
294
Cross Country Healthcare
CCRN
$460M
| $14K | ﹤0.01% |
+1,176
| New | +$14K |
|
295
Chemed
CHE
$6.74B
| $14K | ﹤0.01% |
32
+10
| +45% | +$4.38K |
|
296
Quest Diagnostics
DGX
$20.4B
| $14K | ﹤0.01% |
132
+41
| +45% | +$4.35K |
|
297
Huron Consulting
HURN
$2.42B
| $14K | ﹤0.01% |
203
+56
| +38% | +$3.86K |
|
298
LifeVantage
LFVN
$150M
| $14K | ﹤0.01% |
+923
| New | +$14K |
|
299
LeMaitre Vascular
LMAT
$2.16B
| $14K | ﹤0.01% |
389
+93
| +31% | +$3.35K |
|
300
Masimo
MASI
$8.05B
| $14K | ﹤0.01% |
89
-94
| -51% | -$14.8K |
|